Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
887.30
-16.25 (-1.80%) Natco Pharma informs about press release
Date: 29-11-2016Natco Pharma has informed about a Press Release dated November 29, 2016, titled ‘Natco receives Final Approval for Generic Armodafinil Tablets for USA Market’.
The above information is a part of company’s filings submitted to BSE.